Stock screener

MLYS

Conviction 11HealthcareScan · Thu, Sep 24, 2026

Mineralys Therapeutics, Inc. (MLYS) closed at $26.61 (-1.04%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 45, RS Rating 21, -43.8% from its 52-week high, -25.5% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

MLYS$26.61-1.04%
ResistanceSupportVol 14Insider sell
63 bars
2
2
Vol MA14 1.55M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Mineralys Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSmineralystx.com ↗
Price26.61
Change-1.04%
Gap-0.39%
Rel volume1.11×
Avg volume1.4M
Avg $ vol39.77M
SMA 2028.01
SMA 5027.14
SMA 20028.78
Price vs 50-1.95%
Price vs 200-7.54%
MA stackbearish
50/200 cross—
Supertrendup · 26.53
RSI (14)45
MACD hist-0.22
MACD crossbear · 1d
Stoch %K / %D12 / 25
ADX (14)15
+DI / −DI23 / 26
RSI divergence—
MACD divergence—
ATR %5.70%
ADR %5.60%
52w high47.33
52w low22.50
From 52w high-43.78%
Above 52w low+18.27%
New 52w highNo
SqueezeOff
Bollinger width21.93%
%B0.27
Donchian pos23.25%
Donchian high31.99
Donchian low24.98
AVWAP (52w high)30.10
vs AVWAP high-11.58%
AVWAP (52w low)26.76
vs AVWAP low-0.54%
OBV trendFlat
Chaikin MF (20)0.08
Today vs 20d1.11×
Avg vol (14d)1.55M
Avg vol (20d)1.4M
Avg $ vol (20d)39.77M
Market cap2.35B
RS Rating21 / 99
RS 3m (vs SPY)-3.47%
RS 6m (vs SPY)-8.73%
RS line new highNo
Trend template0/8
Technical rank52.8
1 week-4.90%
1 month+1.03%
3 months+1.03%
6 months+8.08%
1 year-29.32%
YTD-25.48%
P/E-15.21
P/B4.27
P/S—
P/FCF-16.52
EPS-2.29
Div yield—
ROE-28.07%
ROA-23.16%
Debt/Eq0.00
Current34.46
EV/EBITDA-12.98
Gross margin—
Net margin—
Rev growth—
EPS growth13.02%
Price target51.00
Target upside91.66%
Analyst ratingBuy
Institutional117.22%
Ent. value2.21B
Revenue—
Net income-241.07M
Gross profit—
Free cash flow-142.43M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out82.5M
Employees76
ListedFri, Feb 10, 2023
Free float50.59M
Float %63.9%
Short interest9.33M
Days to cover11.4d
Short volume61.0%
Squeeze score78 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$2.85 vs −$0.57
Last surprise-400.0% miss
Setup gradeD
Conviction11 / 100
Pattern quality—
Tech rank52.8 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance30.76
Support24.96
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in MLYS

All disclosures →
No recent disclosed trades by Congress in MLYS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in MLYS · open-market 2 sells

InsiderSideShares
Karydas Daphne
Director · Stock Option · 2026-09-15
Exercise3K
Karydas Daphne
Director · Common Stock · 2026-09-15
Sell3K
Karydas Daphne
Director · Common Stock · 2026-09-15
Exercise3K
Warren Eric
Chief Commercial Officer · Common Stock · 2026-08-21
Exercise7.44K
Warren Eric
Chief Commercial Officer · Common Stock · 2026-08-21
Sell7.44K
Warren Eric
Chief Commercial Officer · Stock Option · 2026-08-21
Exercise7.44K
Rodman David Malcom
Chief Medical Officer · Stock Option · 2026-08-10
Exercise2.17K
Ferguson James J. III
Chief Medical Officer · Common Stock · 2026-08-10
Grant102.4K
Ferguson James J. III
Chief Medical Officer · Stock Option · 2026-08-10
Grant135K
Rodman David Malcom
Chief Medical Officer · Common Stock · 2026-08-10
Exercise2.17K

SEC filings

EDGAR filings in MLYS · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.